Akebia Therapeutics
AKBA
AKBA
57 hedge funds and large institutions have $94.4M invested in Akebia Therapeutics in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
44% less capital invested
Capital invested by funds: $170M → $94.4M (-$75.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
57
Holding in Top 10
–
Calls
$391K
Puts
$107K
Top Buyers
1 | +$9.12M | |
2 | +$3.13M | |
3 | +$2.67M | |
4 |
Millennium Management
New York
|
+$814K |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$782K |
Top Sellers
1 | -$3.97M | |
2 | -$3.9M | |
3 | -$3.68M | |
4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.28M |
5 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$3.2M |